Bardet-Biedl Syndrome
0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Peptide
1100%
+ 3 programs with unclassified modality
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Rhythm PharmaceuticalsBOSTON, MA
2 programsSetmelanotidePHASE_3Peptide1 trial
Setmelanotide 2 mgPHASE_31 trial
Active Trials
Human BioSciencesWV - Martinsburg
1 programGenetics and Clinical Characteristics of Bardet-Biedl SyndromeN/A1 trial
Active Trials
Genome & CompanyKorea - Suwon
1 programGenetics and Clinical Characteristics of Bardet-Biedl SyndromeN/A
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Rhythm PharmaceuticalsSetmelanotide
Rhythm PharmaceuticalsSetmelanotide 2 mg
Human BioSciencesGenetics and Clinical Characteristics of Bardet-Biedl Syndrome
Clinical Trials (3)
Total enrollment: 225 patients across 3 trials
Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity
Start: Mar 2022Est. completion: Nov 202412 patients
Phase 3Completed
Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Participants With Specific Gene Defects in the MC4R Pathway
Start: Dec 2021Est. completion: Oct 202319 patients
Phase 3Completed
Genetics and Clinical Characteristics of Bardet-Biedl Syndrome
Start: Feb 2004Est. completion: Feb 2016194 patients
N/ATerminated
Related Jobs
Business Operations Support – Germany, Switzerland, Austria (GSA)
1mo ago
Area Development Manager (West)
2mo ago
$135K - $215K/yr
Area Development Manager (Southeast)
2mo ago
$135K - $215K/yr
Area Development Manager (South)
2mo ago
$135K - $215K/yr
Area Development Manager (Northwest)
2mo ago
$135K - $215K/yr
Office & Operations Manager, The Netherlands
2mo ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.